2017 – DCB12

Program – RegistrationOrganiser & Contact – Evaluation DCB11 – Sponsors


15578032_1184708471582348_5558253319881178093_o

CRISPR based technologies and bio-products

12 Danish Conference on Biotechnology and Molecular Biology (DCB12)

Thursday, June 01 – Friday, June 02, 2017

Hotel Munkebjerg, Vejle 

Hosted by the Danish Biotechnological Society (DBS)

Download: DCB12 Synopsis

Genome editing and the utilization of CRISPR based technologies are expected to revolutionize the production of the next generation of bioproducts. DCB12 will focus on the latest developments in the use of CRISPR/Cas9 and other CRISPR based technologies in relation to the development and production of biopharmaceuticals, biochemicals, agricultural crops and translational applications.

– Program

The conference will include sessions on:

  • Drug screening
  • Production of bio-pharmaceuticals
  • Therapeutics
  • Plant cell factories and agro-science
  • Mammalian and microbial cell factories
  • Legal and regulatory aspects
  • Tools and future directions

Accepted speakers

  • Alex Toftegaard Nielsen, The Technical University of Denmark, DK
  • Birger Lindberg Møller, University of Copenhagen, DK
  • Claudio Mussolino, University Medical Center Freiburg, D
  • Gorm Greisen, The Danish Council on Ethics, DK
  • Helene Faustrup Kildegaard, NNF Biosustainability Centre, The Technical University of Denmark, DK
  • Jon Chesnut, Thermo Fisher Scientfic, USA
  • Leslie Mitchell, New York University, Langone Medical Center, USA
  • Lorenz Mayer, AstraZeneca, UK
  • Mark Behlke, Integrated DNA Technologies, USA
  • Matthew H. Porteus, Stanford University, USA
  • Pascale Daran-Lapujade, Delft University, NL
  • Sofia Håkansson Buch, Novo Nordisk A/S, DK.
  • Philippe Horvath, DuPont-Danisco, F.
  • Philip Webber, Dehns Patent & Trade Mark Attorneys, UK
  • TBA, Millipore Sigma, USA

Download: Conference Tentative Program

– Registration

Please use the appropriate registration link below:

Registration for participants (at IDA website)

Registration for invited speakers

Registration for exhibitors

Deadline for poster abstracts and registration: May 1, 2017.

Posters

The conference will include a poster session. Please submit your abstract using the link below.

Abstract Submission

Posters and invited speakers please use the link below.
Deadline for poster abstracts and registration: May 1, 2017.

Submit abstract

– Organiser & Contact

If you have any questions please feel free to contact us:

  • Participants: Anne Dalgaard, ada@ida.dk
  • Invited speakers: Eric Paul Bennett, epb@sund.ku.dk
  • Poster abstracts: Lars Haastrup Pedersen, lhp@bio.aau.dk
  • Exhibitors: Carola Heesemann Rosenkilde, chee@biosustain.dtu.dk

Danish Biotechnological Society (DBS) is a scientific society established in 2006 in collaboration between Danish Biotechnology Forum and The Danish Society for Biochemistry and Molecular Biology. DBS is organised as part of The Danish Society of Engineers, IDA Biotechnology.

The purpose of DBS is to facilitate networking within the field of biotechnology in Denmark, creating links between universities, research institutions, hospitals and companies. DBS represents professionals working with biotechnology and seeks to promote and communicate important issues on biotechnology, biochemistry and molecular biology to the public. DBS organises scientific conferences and meetings on biotechnology.

The conference was organised in collaboration with Danish Society of Biochemistry and Molecular Biology.

– Evaluation of DCB11

In general the participants was happy about the organisation of the conference, and the ability to network. Most of the researchers who participated at the conference considered themselves as researchers within basic research.

Full evaluation of the 2016 conference

– Sponsors

2017_IDT logo (1)

 

Novo logo